Hypovitaminosis D and associated cardiometabolic risk in women with PCOS

Journal of Clinical and Diagnostic Research

Volumn 10, Issue 5, 2016, Pages 1-4

  Mishra, Sanjukta ^a   Das, Ashok Kumar ^a   Das, Swarnalata ^a  

^a KIIT UNIVERSITY   (India)

Author keywords

Dyslipidemia; Insulin resistance; Polycystic ovary syndrome; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; C REACTIVE PROTEIN; FOLLITROPIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LUTEINIZING HORMONE; TESTOSTERONE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; BODY MASS; CARDIOMETABOLIC RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; HUMAN; HYPERANDROGENISM; HYPERINSULINEMIA; INSULIN RESISTANCE; OVARY POLYCYSTIC DISEASE; PROSPECTIVE STUDY; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; VITAMIN D DEFICIENCY;

EID: 84966359085     PISSN: 2249782X     EISSN: 0973709X     Source Type: Journal    
DOI: 10.7860/JCDR/2016/19407.7771     Document Type: Article

References (32)

1. Frank S. Polycystic Ovary Syndrome. N Engl J Med. 1995;333:853-61.
2. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Hum Reprod. 2004;19(1):41-47.
3. Executive summary of the third report of the National Cholesterol Education Programme (NCEP). Expert panel on detection, evaluation and treatment of high cholesterol in adult (Adult treatment panel III). JAMA. 2001;285:2486-97.
4. Carmina E. Metabolic syndrome in Polycystic ovary syndrome. Minerva Ginecol. 2006;58(2):109-14.
5. Paradisi G, Steinberg HO, Hempfling A, Cronin J, Hook G, Shepard MK, et al. Polycystic ovary syndrome is associated with endothelial dysfunction. Circulation. 2001;103(10):1410-15.
6. Holick MF. Vitamin D deficiency. New Engl J Med. 2007;357(3):266-68.
7. Heaney RP. Vitamin D in health and disease. Clin J Am Soc Nephrol. 2008;3(5):1535-41.
8. Arya V, Bhambri R, Godbole MM, Mithal A. Vitamin D status and its relationship with bone mineral density in healthy Asian Indians. Osteoporos Int. 2004;15:56-61.
9. Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation. 2008;117: 503-11.
10. Hahn S, Haselhorst U, Trans S, Quadbeck B, Schmidt M, Roesler S, et al. Low seum 25-hydroxy Vitamin D concentrations are associated with insulin resistance and obesity in women with polycystic ovary syndrome. Exp Clin Endocrinol Diabetes. 2006;114:577-83.
11. Wehr E, Pilz S, Schweighofer N, Giuliani A, Kopera D, Pieber TR, et al. Association of hypovitaminosis D with metabolic disturbances in Polycystic ovary syndrome. Eur. J Endocrinology. 2009;161:575-82.
12. Rotterdam ESHRE/ASRM-Sponsered polycystic ovary syndrome consensum Workshop Group. “Revised 2003 consensus on diagnostic criteria and long term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;82(suppl 3):1193-97.
13. Mathews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: Insulin resistance and beta cell function from plasma fasting glucose and insulin concentrations in man. Diabetologia. 1985;28:412-19.
14. Pittas G, Chung M, Trikalinos T, Mitri J, Brendel M, Patel K, et al. Vitamin D and Cardiometabolic outcomes: A systematic Review. Ann Intern Med. 2010;152(5):307-14.
15. Wang L, Manson JE, Song Y, Sesso HD. Systemic review: Vitamin D and calcium supplementation in prevention of cardiovascular events. Ann Intern Med. 2010;152:315-23.
16. Cheung LP, Ma RC, Lam PM, Lok IH, Haines CJ, So WY, et al. Cardiovascular risk and metabolic syndrome in Hong Kong Chienese women with PCOS. Hum Reprod. 2008;23(6):1431-38.
17. Rahimi-Aradabili H, Poughassem Gargari B, Farzadi L. Effects of Vitamin D on cardiovascular risk factors in polycystic syndrome in women with Vitamin D deficiency. J Endocrino Invest. 2013;36:28-32.
18. Li H WR, Brereton RE, Anderson RA, Wallace AM, Ho CK. Vitamin D deficiency is common and associated with metabolic risk factors in patients with Polycystic ovary syndrome. Metabolism. 2011;60:1475-81.
19. Pal L, Shu J, Zeitlian G, Hickmon C. Vitamin D insufficiency in reproduction years may be contributory to ovulatory infertility and Polycystic ovary syndrome. Fertil steril. 2008;90:S14.
20. Mahmoudi T, Gourabi H, Ashrafi M, Yazdi RS, Ezabadi Z. Calcitropic hormones, insulin resistance, and the polycystic Polycystic ovary syndrome. Fertil steril. 2010;93(4):1208-14.
21. Unal AD, Tarcin O, Cigerli O, Takir M, Parildar H, Ergen N, et al. Vitamin D levels in Polycystic ovary syndrome patients is not different from healthy controls in Turkish population. Endocrine Abstracts. 2013;32:608.
22. Rashidi B, Haghollahi F, Shariat M, Zayerii F. The effect of calcium-Vit D and metformin on Polycystic ovary syndrome: A pilot study. Taiwan J Obstet Gynecol. 2009;48(2):142-47.
23. Mahmoudi T. Genetic variation in the Vitamin D receptor and Polycystic ovary syndrome risk. Fertil Steril. 2009;92:1381-83.
24. Richardson MR. Current perspectives in polycystic ovary syndrome. Am Fam Physician. 2003;68:697-704.
25. Rocha MP, Maranho RC, Seydel TM, Barcellor CR, Baracat EC, Hayashida SA, et al. Metabolism of triglyceride-rich lipoprotein and lipid transfer to high density lipoprotein in young obese and normal weight patient with Polycystic ovary syndrome. Fertil Steril. 2010;93(6):1948-56.
26. Boulman N, Levy Y, Lebia R, Shachar S, Linn R, Zinder O, et al. Increased C-reactive protein levels in the Polycystic Ovary Syndrome: A Marker of Cardiovascular Disease. J Clin Endocrinol Metab. 2004;89(5):2160-65.
27. Tosi F, Dorizzi R, Castello R, Maffeis C, Spiazzi G, Zoppini G, et al. Body fat and insulin resistance independently predict increased serum C-reactive protein in hyperandrogenic womem with polycystic ovary syndrome. Eur J Endocrinol. 2009;161:737-45.
28. Alvarez JA, Ashraf A. Role of Vitamin D in Insulin secraetion and Insulin Sensitivity for glucose homeostasis. Int J Endocrinol. 2010;2010:351385.
29. Wehr E, Piebr TR, Obermayer-Pietsch B. Effect of Vitamin D3 treatment on glucose metabolism and menstrual frequency in polycystic ovary syndrome: A pilot study. J Endocrinol Invest. 2011;34(10):757-63.
30. Freundlich M, Quiroz Y, Zhang Z, Zhang Y, Bravo Y, Weisinger JR, et al. Suppression of rennin-angiotension gene expression in kidney by paricalcitol. Kidney International. 2008;74:1394-402.
31. Yildizham R, Kurdoglu M, Adali E, Kolusari A, Yildizhan B, Sahin HG, et al. Serum 25 hydroxy Vitamin D concentrations in obese and non-obese women with polycystic ovary syndrome. Arch Gyanecol Obstet. 2009;280(4):559-63.
32. Selimoglu H, Duran C, Kiyici S, Ersoy C, Guclu M, Ozkaya G, et al. The effect of Vitamin D replacement therapy on insulin resistance and androgen levels in women with polycystic ovary syndrome. J Endocrino Invest. 2010;33(4):234-38.